Digital Health Messages

Uses

Benefits

Preparation

Risks & contraindications

Background

Highlighted claims

• Messages judged inaccurate, inappropriate or not ready for patients will not be publicly released or sent beyond the panel. — A double-blind, crossover, non-inferiority randomised controlled trial where primary care providers and patients compare human-generated and AI-generated digital health messages: the AI-CARE study protocol
• Messages in AI-CARE are produced in short and longer patient handout formats. — A double-blind, crossover, non-inferiority randomised controlled trial where primary care providers and patients compare human-generated and AI-generated digital health messages: the AI-CARE study protocol
• The Canadian Primary Care Information Network previously sent digital health messages to more than 90,000 patients across Canada. — A double-blind, crossover, non-inferiority randomised controlled trial where primary care providers and patients compare human-generated and AI-generated digital health messages: the AI-CARE study protocol
• Primary care practices need timely, accurate, understandable and accessible communication but often lack the resources to produce it. — A double-blind, crossover, non-inferiority randomised controlled trial where primary care providers and patients compare human-generated and AI-generated digital health messages: the AI-CARE study protocol
• Proactive digital messages may help patients access reliable information and counter misinformation. — A double-blind, crossover, non-inferiority randomised controlled trial where primary care providers and patients compare human-generated and AI-generated digital health messages: the AI-CARE study protocol